GlassScriptPhysician profile
Siavash Saadat
NPI 1033406491
$6,378.20
in general payments reported to CMS, 2019-2025
9 companies · $687 in 2025
The $687 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,006 · 2020: $714 · 2021: $70.20 · 2022: $1,984 · 2023: $104 · 2024: $815 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,100 · Travel and Lodging: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.50 |
| Travel and Lodging | $505.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,157.19 | 2019-2024 | |
| Edwards Lifesciences Corporation | $1,384.36 | 2019 | |
| Medtronic, INC. | $665.22 | 2022-2025 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $451.59 | 2019 | |
| Alexion Pharmaceuticals, INC. | $416.65 | 2025 | Ultomiris |
| Artivion, INC. | $114.52 | 2024 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Abbott Laboratories | $109.06 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Genentech, INC. | $41.54 | 2024 | |
| Abiomed | $38.07 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Siavash Saadat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.